Premenopausal Osteoporosis
- PMID: 28131128
- PMCID: PMC5412712
- DOI: 10.1016/j.ecl.2016.09.007
Premenopausal Osteoporosis
Abstract
Most premenopausal women with low trauma fracture(s) or low bone mineral density have a secondary cause of osteoporosis or bone loss. Where possible, treatment of the underlying cause should be the focus of management. Premenopausal women with an ongoing cause of bone loss and those who have had, or continue to have, low trauma fractures may require pharmacologic intervention. Clinical trials provide evidence of benefits of bisphosphonates and teriparatide for bone mineral density in several types of premenopausal osteoporosis, but studies are small and do not provide evidence regarding fracture risk reduction.
Keywords: Osteoporosis treatment; Premenopausal women; Secondary causes of osteoporosis.
Copyright © 2016 Elsevier Inc. All rights reserved.
References
-
- Gourlay ML, Brown SA. Clinical considerations in premenopausal osteoporosis. Arch Intern Med. 2004;164:603–14. - PubMed
-
- Khan AA, Syed Z. Bone densitometry in premenopausal women: synthesis and review. J Clin Densitom. 2004;7:85–92. - PubMed
-
- Leib ES. Treatment of low bone mass in premenopausal women: when may it be appropriate? Curr Osteoporos Rep. 2005;3:13–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical